Prestige Consumer Healthcare (NYSE:PBH) Now Covered by Canaccord Genuity Group

Equities research analysts at Canaccord Genuity Group started coverage on shares of Prestige Consumer Healthcare (NYSE:PBHGet Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $71.00 price target on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 21.49% from the company’s current price.

PBH has been the subject of a number of other reports. Oppenheimer decreased their price objective on Prestige Consumer Healthcare to $63.00 in a report on Thursday, September 29th. StockNews.com began coverage on Prestige Consumer Healthcare in a research report on Wednesday, October 12th. They set a “buy” rating for the company. Finally, DA Davidson reissued a “neutral” rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, August 9th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $68.75.

Prestige Consumer Healthcare Stock Up 0.2 %

NYSE:PBH opened at $58.44 on Wednesday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.29 and a current ratio of 2.21. The company has a market cap of $2.89 billion, a PE ratio of 14.18, a PEG ratio of 1.75 and a beta of 0.55. Prestige Consumer Healthcare has a 52-week low of $48.51 and a 52-week high of $63.47. The stock has a 50-day simple moving average of $52.86 and a 200 day simple moving average of $55.15.

Institutional Trading of Prestige Consumer Healthcare

A number of hedge funds have recently made changes to their positions in PBH. Meeder Asset Management Inc. lifted its position in shares of Prestige Consumer Healthcare by 79.0% in the second quarter. Meeder Asset Management Inc. now owns 451 shares of the company’s stock valued at $27,000 after buying an additional 199 shares during the last quarter. Global Retirement Partners LLC lifted its position in shares of Prestige Consumer Healthcare by 3,435.7% in the third quarter. Global Retirement Partners LLC now owns 495 shares of the company’s stock valued at $27,000 after buying an additional 481 shares during the last quarter. Lindbrook Capital LLC lifted its position in shares of Prestige Consumer Healthcare by 3,000.0% in the second quarter. Lindbrook Capital LLC now owns 496 shares of the company’s stock valued at $29,000 after buying an additional 480 shares during the last quarter. Ronald Blue Trust Inc. lifted its position in shares of Prestige Consumer Healthcare by 349.3% in the third quarter. Ronald Blue Trust Inc. now owns 602 shares of the company’s stock valued at $36,000 after buying an additional 468 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its position in shares of Prestige Consumer Healthcare by 474.7% in the third quarter. Quadrant Capital Group LLC now owns 1,092 shares of the company’s stock valued at $54,000 after buying an additional 902 shares during the last quarter. 99.37% of the stock is owned by institutional investors and hedge funds.

About Prestige Consumer Healthcare

(Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Stories

The Fly logo

Analyst Recommendations for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.